Apr 11 |
Fulgent Genetics to Announce First Quarter 2024 Financial Results on Friday, May 3, 2024
|
Apr 11 |
Fulgent Genetics (NASDAQ:FLGT) shareholders have earned a 26% CAGR over the last five years
|
Mar 1 |
An Intrinsic Calculation For Fulgent Genetics, Inc. (NASDAQ:FLGT) Suggests It's 32% Undervalued
|
Mar 1 |
Fulgent Genetics Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags
|
Feb 29 |
Fulgent Genetics, Inc. (NASDAQ:FLGT) Q4 2023 Earnings Call Transcript
|
Feb 29 |
Q4 2023 Fulgent Genetics Inc Earnings Call
|
Feb 28 |
Fulgent Genetics (FLGT) Q4 2023 Earnings Call Transcript
|
Feb 28 |
Fulgent Genetics Inc (FLGT) Faces GAAP Loss Despite Core Revenue Growth in 2023
|
Feb 28 |
Fulgent Genetics Non-GAAP EPS of $0.28 beats by $0.57, revenue of $70.51M beats by $4.19M
|
Feb 28 |
Fulgent Reports Fourth Quarter and Full Year 2023 Financial Results
|